Lang, Judith http://orcid.org/0000-0001-5352-106X
Bohn, Patrick
Bhat, Hilal
Jastrow, Holger
Walkenfort, Bernd
Cansiz, Feyza
Fink, Julian
Bauer, Michael http://orcid.org/0000-0002-8156-4603
Olszewski, Dominik
Ramos-Nascimento, Ana
Duhan, Vikas
Friedrich, Sarah-Kim
Becker, Katrin Anne
Krawczyk, Adalbert
Edwards, Michael J.
Burchert, Andreas
Huber, Magdalena
Friebus-Kardash, Justa
Göthert, Joachim R.
Hardt, Cornelia
Probst, Hans Christian http://orcid.org/0000-0002-7926-0651
Schumacher, Fabian http://orcid.org/0000-0001-8703-3275
Köhrer, Karl http://orcid.org/0000-0003-3644-2022
Kleuser, Burkhard
Babiychuk, Eduard B.
Sodeik, Beate http://orcid.org/0000-0003-4650-3036
Seibel, Jürgen
Greber, Urs F. http://orcid.org/0000-0003-2278-120X
Lang, Philipp A.
Gulbins, Erich http://orcid.org/0000-0002-3117-1342
Lang, Karl S.
Article History
Received: 25 July 2019
Accepted: 17 February 2020
First Online: 12 March 2020
Competing interests
: J.L., M.J.E., E.G., and K.S.L. declare that they have applied for a patent related to the treatment of viral infections with sphingosine. Patent applicant: Harbins Ruhr Bioscience; name of inventors: Erich Gulbins, Karl Lang, Judith Lang; application number: DE 102018217334.6 (German), 57HARB10052WO 16/588,361 (USA); status of application: pending; specific aspect of manuscript covered in patent application: claims on the basis of data shown in Fig. InternalRef removed, h, i. The remaining authors declare no competing interests.